✦ LIBER ✦

UGT1A1 promoter polymorphism increases risk of nilotinib-induced hyperbilirubinemia

✍ Scribed by Singer, J B; Shou, Y; Giles, F; Kantarjian, H M; Hsu, Y; Robeva, A S; Rae, P; Weitzman, A; Meyer, J M; Dugan, M

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Severe Neonatal Hyperbilirubinemia and U

✍ Travan, Laura; Lega, Sara; Crovella, Sergio; Montico, Marcella; Panontin, Elisa; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 175 KB

T1783 The Functional UDP-Glucoronosyltra

✍ Huang, Yi-Shin 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 72 KB

UGT1A1*28and*6polymorphisms and nilotini

✍ Kohichi Takada, Tsutomu Sato, Satoshi Iyama, Kaoru Ono, Yusuke Kamihara, Kazuyuk 📂 Article 📅 2012 🏛 Springer Japan ⚖ 215 KB

Do UGT1A1 and HMOX1 gene promoter polymo

✍ Warang, Prashant; Devendra, Rati; D’Silva, Selma; Chiddarwar, Ashish; Kedar, Pra 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 102 KB

Pazopanib-induced hyperbilirubinemia is

✍ Xu, C-F; Reck, B H; Xue, Z; Huang, L; Baker, K L; Chen, M; Chen, E P; Ellens, H 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 431 KB

1114 Pazopanib-induced hyperbilirubinemi

✍ C. Xu; B. Reck; Z. Xue; L. Huang; K. Baker; M. Chen; V. Mooser; L. Cardon; C. Sp 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB